Click here to find out more about what’s new in the Gibco portfolio!
This week's FierceBiotech is brought to you by BD Pharmaceutical Systems. Trouble viewing? Click here. |
| | | THE DIFFERENCE OF GOING TO MARKET WITH CONFIDENCE |
| |
|
System integration can affect the success of a drug program, and we recognize that it’s important to de-risk the delivery system to control development timelines, operational costs, drug delivery and patient acceptance. The goals of the webinar: to share insights about our system integration to explain why it matters for combination product performance to provide concrete examples of the positive performance a robust system integration approach can enable Experience matters. Learn how BD is informing robust, well-designed combination products to ensure they achieve their desired functionality, and ultimately, enable their performance in the market. |
|
|
| BD and the BD Logo are trademarks of Becton, Dickinson and Company or its affiliates. © 2019 BD. All rights reserved. | |
|
|
Want to reach 137,000+ FierceBiotech subscribers with your own message? Contact [email protected] or call 202-824-5074.
About this email: In order to receive FierceBiotech for free, we ask that you accept an occasional email promotion from our sponsors. We carefully screen each promotion and never sell or give away your personal information. If you do not want to receive these messages, you can unsubscribe entirely from FierceBiotech. Click here to unsubscribe. Refer to our Privacy Policy. FierceMarkets, a division of Questex, LLC 1900 L St. NW Suite 400 Washington, DC 20036 |